
pmid: 2678349
AbstractWe summarize some of the recent work on the errors‐in‐variables problem in generalized linear models. The focus is on covariance analysis, and in particular testing for and estimation of treatment effects. There is a considerable difference between the randomized and non‐randomized models when testing for an effect. In randomized studies, simple techniques exist for testing for a treatment effect. In some instances, such as linear and multiplicative regression, simple methods exist for estimating the treatment effect. In other examples such as logistic regression, estimating a treatment effect requires careful attention to measurement error. In non‐randomized studies, there is no recourse to understanding and modelling measurement error. In particular ignoring measurement error can lead to the wrong conclusions, for example the true but unobserved data may indicate a positive effect for treatment, while the observed data indicate the opposite. Some of the possible methods are outlined and compared.
Analysis of Variance, Linear Models, Humans, Regression Analysis, Randomized Controlled Trials as Topic
Analysis of Variance, Linear Models, Humans, Regression Analysis, Randomized Controlled Trials as Topic
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 71 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 1% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
